POU6F2 and colorectal carcinoma: Furthermore, we generated patient-derived organoid (PDO) from CRC patient tissues and found that POU6F2-AS1 knockdown suppressed PDO formation, while POU6F2-AS1 overexpression facilitated PDO formation (Fig. 2G, H).